Lipohypertrophy and Insulin: An Update From the Diabetes Technology Society. Academic Article uri icon

Overview

abstract

  • Lipohypertrophy is a common skin complication associated with insulin-treated diabetes. The impact of lipohypertrophy as a contributing factor to suboptimal glycemic control, glucose variability, and hypoglycemia is often under-recognized by health care professionals. In a recent Webinar on April 26, 2023, Diabetes Technology Society asked international experts to provide updates on the latest knowledge related to lipohypertrophy for practicing clinicians and educators, researchers, and industries involved in insulin delivery. A recording of the Webinar is freely available on the Diabetes Technology Society Web site (https://www.diabetestechnology.org/).

publication date

  • August 9, 2023

Research

keywords

  • Diabetes Mellitus, Type 1
  • Hypoglycemia
  • Lipodystrophy

Identity

PubMed Central ID

  • PMC10658672

Scopus Document Identifier

  • 85167448293

Digital Object Identifier (DOI)

  • 10.1177/19322968231187661

PubMed ID

  • 37555266

Additional Document Info

volume

  • 17

issue

  • 6